A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza
Authors:
- Nicasio ManciniNMNicasio Mancini
- Laura SolforosiLSLaura Solforosi
- Nicola ClementiNicola Clementi
- Donata De MarcoDMDonata De Marco
- Massimo ClementiMCMassimo Clementi
- Roberto BurioniRBRoberto Burioni
- 1 October 2011
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 92 (1) , 15-26
Abstract
No abstract availableKeywords
This publication has 174 references indexed in Scilit:
- A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infectionAntiviral Research, 2010
- Glycans on influenza hemagglutinin affect receptor binding and immune responseProceedings of the National Academy of Sciences, 2009
- Influenza control in the 21st century: Optimizing protection of older adultsVaccine, 2009
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesNature Structural & Molecular Biology, 2009
- Isolation of human monoclonal antibodies by mammalian cell displayProceedings of the National Academy of Sciences, 2008
- Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivorsNature, 2008
- Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platformVaccine, 2008
- Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategiesProceedings of the National Academy of Sciences, 2008
- Current and future antiviral therapy of severe seasonal and avian influenzaAntiviral Research, 2008
- Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolutionNature, 1981